Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Q9WO
|
||||
| Former ID |
DAP001250
|
||||
| Drug Name |
Cinolazepam
|
||||
| Synonyms |
Cinolazepamum; Gerodorm; Cinolazepam [INN]; OX 373; Cinolazepam (INN); Cinolazepamum [INN-Latin]; Gerodorm (TN); OX-373;1-(2-cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]propanenitrile; 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-3H-1,4-benzodiazepin-1-yl]propanenitrile; 7-Chloro-5-(o-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile; 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Muscle relaxant [ICD10:N39.3, N39.4, R32] | Approved | [550708] | ||
| Therapeutic Class |
Anticonvulsants
|
||||
| Formula |
C18H13ClFN3O2
|
||||
| Canonical SMILES |
C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CCC#N)O)F
|
||||
| InChI |
1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2
|
||||
| InChIKey |
XAXMYHMKTCNRRZ-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 75696-02-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| SuperDrug ATC ID |
N05CD13
|
||||
| SuperDrug CAS ID |
cas=075696025
|
||||
| Target and Pathway | |||||
| Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Binder | [537708] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| HTLV-I infection | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.